Chunxia Chen

7.4k citations
179 papers · 5.9k · 3 hit papers · h-index 36

Impact in

  • Immunology top 2%
    • T-cell and B-cell Immunology
  • Hepatology top 2%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • T-cell and B-cell Immunology 11
    • Immunotherapy and Immune Responses 5
    • Cancer Immunotherapy and Biomarkers 5

Chunxia Chen

167 papers receiving 5.8k citations

Chunxia Chen's Hit Papers

Mitigation of ischemia/reperfusion injury via selenium nanoparticles: Suppression of STAT1 to inhibit cardiomyocyte oxidative stress and inflammation 2025 · 28 citations
280+2+4Years since publication100200300400

Peers

Chunxia Chen
Comparison fields: 5 of 143
  • Immunology 1k
  • Hepatology 365
  • Oncology 832
  • Molecular Biology 1.6k
  • Cancer Research 303
Replace Rongxin Zhang with:
Rongxin Zhang China
Nelson Hirokazu Tsuno Japan
Nariyoshi Shinomiya Japan
Patricia J. Sime United States
Gerhard Krönke Germany
Jing Zhou China
Seong‐Jin Kim South Korea
Min Hee Yang China
Cong Peng China
Xiaoli Wang China
Chunxia Chen relative to Rongxin Zhang China Rongxin Zhang's profile →
Citations per field
00.5×1.7×
Rongxin Zhang · 1×
Citations per year

Countries citing papers authored by Chunxia Chen

Since Specialization
Citations

This map shows the geographic impact of Chunxia Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunxia Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunxia Chen more than expected).

Fields of papers citing papers by Chunxia Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunxia Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunxia Chen. The network helps show where Chunxia Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Chunxia Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chunxia Chen Line = papers co-authored together Chunxia Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 179 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2007814
2
Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial
Hit paper breakdown →
2020477
3 2000439
4
Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial
Hit paper breakdown →
2021324
5 2006189
6 2000180
7 1997168
8 2020106
9 202099
10 201098
11 201395
12 201288
13 201787
14 200779
15 201269
16 201662
17 201156
18 202356
19 200955
20 201655

About Chunxia Chen

Chunxia Chen is a scholar working on Immunology, Oncology, Pathology and Forensic Medicine, Cancer Research and Computer Vision and Pattern Recognition, having authored 179 papers that have together received 5.9k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (11 papers), Medical Image Segmentation Techniques (7 papers), Cardiac Ischemia and Reperfusion (7 papers), AI in cancer detection (6 papers), Breast Cancer Treatment Studies (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers) and Posttraumatic Stress Disorder Research (5 papers). The work is most often cited by research in Immunology (1k citations), Hepatology (365 citations), Oncology (832 citations), Molecular Biology (1.6k citations) and Cancer Research (303 citations). Chunxia Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Andrew D. Wells, Kazuko Nishikura, Wayne W. Hancock, Fang Lai, Kenneth C. Carter, Qingde Wang, Liqing Wang, Mark Irwin Greene, Edwin F. de Zoeten and Engin Özkaynak. Their work appears in journals such as PLoS ONE, Journal for ImmunoTherapy of Cancer, International Journal of Radiation Oncology*Biology*Physics, Journal of Biological Chemistry and Neurochemical Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact